1. Home
  2. GH vs SUZ Comparison

GH vs SUZ Comparison

Compare GH & SUZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Guardant Health Inc.

GH

Guardant Health Inc.

HOLD

Current Price

$94.00

Market Cap

13.3B

Sector

Health Care

ML Signal

HOLD

Logo Suzano S.A.

SUZ

Suzano S.A.

HOLD

Current Price

$11.32

Market Cap

11.8B

ML Signal

HOLD

Company Overview

Basic Information
Metric
GH
SUZ
Founded
2011
1924
Country
United States
Brazil
Employees
N/A
N/A
Industry
Medical Specialities
Paper
Sector
Health Care
Basic Materials
Exchange
Nasdaq
Nasdaq
Market Cap
13.3B
11.8B
IPO Year
2018
2002

Fundamental Metrics

Financial Performance
Metric
GH
SUZ
Price
$94.00
$11.32
Analyst Decision
Strong Buy
Analyst Count
20
0
Target Price
$117.80
N/A
AVG Volume (30 Days)
1.9M
3.3M
Earning Date
05-11-2026
01-01-0001
Dividend Yield
N/A
1.68%
EPS Growth
6.74
N/A
EPS
N/A
N/A
Revenue
$982,021,000.00
N/A
Revenue This Year
$29.73
$13.83
Revenue Next Year
$27.71
$13.42
P/E Ratio
N/A
$5.58
Revenue Growth
32.88
N/A
52 Week Low
$34.91
$8.41
52 Week High
$120.74
$11.54

Technical Indicators

Market Signals
Indicator
GH
SUZ
Relative Strength Index (RSI) 36.72 70.70
Support Level $54.39 $9.28
Resistance Level $115.77 N/A
Average True Range (ATR) 6.12 0.24
MACD -1.26 0.06
Stochastic Oscillator 9.73 86.63

Price Performance

Historical Comparison
GH
SUZ

About GH Guardant Health Inc.

Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced-stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant Omni, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease test. In 2024, the company received US FDA approval for Shield, a liquid biopsy for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.

About SUZ Suzano S.A.

Suzano SA produces and sells pulp and a variety of paper products. The company organizes itself into two segments based on product type: Pulp and Paper. The Pulp segment generates the majority of revenue. The firm's product portfolio includes printing and writing paper, paperboard, diapers, and sanitary napkins. The company owns forest land and plants in Brazil, where it harvests timber and turns the timber into pulp and paper in its plants.

Share on Social Networks: